FIELD: pharmacology.
SUBSTANCE: inventions represent: a pharmaceutical composition, a composition of the functional product of therapeutic nourishment, quasimedicine composition for preventing or treating atopic eczema containing monoacetyldiacyl glycerine of formula 2 , as an active ingredient. The invention also includes a method of preventing or treating atopic eczema, comprising of administration to a non-human patient any of the compositions described above.
EFFECT: monoacetyldiacyl glycerine of this invention effectively inhibit the secretion of IL-4 and IgE, without side effects, they are non-toxic and exert an express therapeutic effect.
6 cl, 8 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR DETECTION OF CANCER BLOOD DISEASES OR METASTASIS OF CANCER CONTAINING ACTIVE INGREDIENT MONOACETHYL DIGLYCERIDE COMPOUND | 2014 |
|
RU2632098C2 |
COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCERIDE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS | 2014 |
|
RU2646823C2 |
COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2636615C2 |
COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES CONTAINING MONOACETHYLDIGLYCEROL COMPOUNDS AS ACTIVE INGREDIENT | 2014 |
|
RU2642631C2 |
METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2015 |
|
RU2702122C2 |
STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE | 2019 |
|
RU2798872C2 |
COMPOSITION CONTAINING Actinidia AND METHODS OF THEIR APPLICATION | 2006 |
|
RU2423139C2 |
IMMUNOMODULATORY AGENT, CANCER AGENT AND HEALTHY FOOD CONTAINING MONOACETYLDIACYLGLYCERIN DERIVATIVES | 2005 |
|
RU2341257C2 |
ANTIBODY-DRUG CONJUGATE HAVING IMPROVED STABILITY AND USE THEREOF | 2014 |
|
RU2670748C9 |
LACTOBACILLUS CRISPATUS KBL693 STRAIN AND ITS APPLICATION | 2019 |
|
RU2791561C2 |
Authors
Dates
2018-01-09—Published
2014-09-03—Filed